![]() |
Volumn 2, Issue 3, 2002, Pages 187-192
|
Antiretroviral therapy regimens for neuron-AIDS
a
|
Author keywords
Antiretroviral therapy; Central nervous system; HIV 1; Non nucleoside inhibitor of reverse transcriptase; Nucleoside analogues; Prophylactic; Protease inhibitors; Therapeutic
|
Indexed keywords
ABACAVIR;
AMPRENAVIR;
ANTIRETROVIRUS AGENT;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
INDINAVIR;
LAMIVUDINE;
LAMIVUDINE PLUS ZIDOVUDINE;
LOPINAVIR;
LOPINAVIR PLUS RITONAVIR;
NELFINAVIR;
NEVIRAPINE;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
TENOFOVIR;
TENOFOVIR DISOPROXIL;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AFFECTIVE NEUROSIS;
ARTICLE;
BRAIN DISEASE;
CENTRAL NERVOUS SYSTEM DISEASE;
CEREBROSPINAL FLUID;
CHEMOPROPHYLAXIS;
COGNITIVE DEFECT;
CONTROLLED STUDY;
DEATH;
DEPRESSION;
DRUG PENETRATION;
HEADACHE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IRRITABILITY;
LETHARGY;
MANIA;
MOTOR DYSFUNCTION;
MYOPATHY;
NEUROPROTECTION;
PANIC;
PERIPHERAL NEUROPATHY;
PREDICTION;
PROGNOSIS;
SIDE EFFECT;
VIRUS LOAD;
METHODOLOGY;
REVIEW;
AIDS-ASSOCIATED NEPHROPATHY;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
HUMAN;
HUMANS;
|
EID: 0035986703
PISSN: 15680053
EISSN: None
Source Type: Journal
DOI: 10.2174/1568005023342425 Document Type: Article |
Times cited : (12)
|
References (27)
|